Trial
NCT04395339
GM1 Prophylaxis for WBRT Related Cognitive Dysfunction
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sun Yat-sen University
Collaborators
—
Condition
Brain Metastases
Intervention
Monosialotetrahexosyl ganglioside (GM1)
Why stopped
Difficulty accruing subjects the study accrual was closed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-01